Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients(♦)
David R. Nelson
, Stefan Zeuzem†, Pietro Andreone‡, Peter Ferenci§, Robert Herring||, Donald M. Jensen¶, Patrick Marcellin**, Paul J. Pockros††, Maribel Rodríguez-Torres‡, Lorenzo Rossaro§§, Vinod K. Rustgi||||, Thomas Sepe¶, Mark Sulkowski***, Isaac R. Thomason†††, Eric M. Yoshida‡‡‡, Anna Chan§§§, George Hill||||||
,
Corresponding author
* Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainsville, USA
† Department of Medicine, J.W. Goethe University Hospital, Frankfurt, Germany
‡ Dipartimento di Medicina Clinica, Università di Bologna, Bologna, Italy
§ Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
|| Nashville Gastrointestinal Specialists Inc, Nashville, USA
¶ Center for Liver Diseases, Chicago, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medical Center, USA
** Hôpital Beaujon, Clinchy, France
†† Division of Gastroenterology and Hepatology, The Scripps Clinic, Torrey Pines, USA
‡‡ Fundacion de Investigacion De Diego Santurce, Puerto Rico and Ponce School of Medicine, Puerto Rico, USA
§§ Division of Gastroenterology and Hepatology, University of California, Davis Medical Center, Sacramento, USA
|||| Georgetown University Medical Center, Fairfax, VA, USA
¶¶ University Gastroenterology, Providence, USA
*** Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology, Johns Hopkins University School of Medicine, Baltimore, USA
††† Mountain West Gastroenterology, Transplant Department, Intermountain Medical Center, Salt Lake City, USA
‡‡‡ Division of Gastroenterology, University of British Columbia, Vancouver, BC, Canada
§§§ Roche, Nutley, NJ, USA
|||||| Roche, Palo Alto, CA, USA
Ver másRead
1180
Timeswas read the article
284
Total PDF
896
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 18 | 1 | 19 |
| 2024 November | 20 | 4 | 24 |
| 2024 October | 5 | 3 | 8 |
| 2024 September | 6 | 1 | 7 |
| 2024 August | 5 | 1 | 6 |
| 2024 July | 8 | 2 | 10 |
| 2024 June | 5 | 2 | 7 |
| 2024 May | 7 | 2 | 9 |
| 2024 April | 7 | 4 | 11 |
| 2024 March | 11 | 3 | 14 |
| 2024 February | 5 | 4 | 9 |
| 2024 January | 10 | 5 | 15 |
| 2023 December | 7 | 10 | 17 |
| 2023 November | 3 | 3 | 6 |
| 2023 October | 7 | 4 | 11 |
| 2023 September | 12 | 3 | 15 |
| 2023 August | 13 | 3 | 16 |
| 2023 July | 5 | 2 | 7 |
| 2023 June | 21 | 3 | 24 |
| 2023 May | 43 | 1 | 44 |
| 2023 April | 34 | 0 | 34 |
| 2023 March | 26 | 0 | 26 |
| 2023 February | 26 | 3 | 29 |
| 2023 January | 6 | 1 | 7 |
| 2022 December | 12 | 3 | 15 |
| 2022 November | 14 | 4 | 18 |
| 2022 October | 14 | 6 | 20 |
| 2022 September | 10 | 4 | 14 |
| 2022 August | 25 | 7 | 32 |
| 2022 July | 24 | 5 | 29 |
| 2022 June | 37 | 5 | 42 |
| 2022 May | 27 | 6 | 33 |
| 2022 April | 29 | 7 | 36 |
| 2022 March | 22 | 6 | 28 |
| 2022 February | 11 | 3 | 14 |
| 2022 January | 44 | 5 | 49 |
| 2021 December | 23 | 8 | 31 |
| 2021 November | 17 | 6 | 23 |
| 2021 October | 35 | 8 | 43 |
| 2021 September | 31 | 9 | 40 |
| 2021 August | 47 | 5 | 52 |
| 2021 July | 8 | 10 | 18 |
| 2021 June | 6 | 7 | 13 |
| 2021 May | 11 | 5 | 16 |
| 2021 April | 40 | 15 | 55 |
| 2021 March | 12 | 7 | 19 |
| 2021 February | 5 | 8 | 13 |
| 2021 January | 4 | 7 | 11 |
| 2020 December | 5 | 9 | 14 |
| 2020 November | 6 | 5 | 11 |
| 2020 October | 10 | 2 | 12 |
| 2020 September | 7 | 2 | 9 |
| 2020 August | 2 | 1 | 3 |
| 2020 July | 3 | 1 | 4 |
| 2020 June | 4 | 2 | 6 |
| 2020 May | 2 | 3 | 5 |
| 2020 April | 3 | 0 | 3 |
| 2020 March | 9 | 7 | 16 |
| 2020 February | 3 | 2 | 5 |
| 2020 January | 7 | 3 | 10 |
| 2019 December | 9 | 4 | 13 |
| 2019 November | 2 | 4 | 6 |
| 2019 October | 0 | 5 | 5 |
| 2019 September | 4 | 4 | 8 |
| 2019 August | 1 | 2 | 3 |
| 2019 July | 0 | 3 | 3 |
| 2019 June | 1 | 4 | 5 |
Show all
